IRADIMED CORP (IRMD) Stock Analyst Ratings
USA - NASDAQ:IRMD - US46266A1097 - Common Stock
84.35 USD
-0.15 (-0.18%)
84.35 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to IRMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 76.5. This target is -9.31% below the current price.
IRMD was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IRMD.
In the previous month the buy percentage consensus was at a similar level.
IRMD was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2024-08-02 | Roth MKM | Maintains | Buy -> Buy |
| 2024-04-22 | Roth MKM | Reiterate | Buy |
| 2021-08-02 | Roth Capital | Maintains | Buy |
IRADIMED CORP / IRMD FAQ
What do analysts expect the price target to be for IRADIMED CORP (IRMD)?
8 analysts have analysed IRMD and the average price target is 76.5 USD. This implies a price decrease of -9.31% is expected in the next year compared to the current price of 84.35.
What is the consensus rating for IRMD stock?
The consensus rating for IRADIMED CORP (IRMD) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed IRADIMED CORP (IRMD)?
The number of analysts covering IRADIMED CORP (IRMD) is 8.